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In Brief
Myeloid-derived suppressor cells
(MDSCs) are innate immune cells that
suppress T cell responses. Rieber et al.
show that pathogenic fungi Aspergillus
fumigatus and Candida albicans induce
MDSCs through mechanisms involving
Dectin-1/CARD as well as downstream
ROS and IL-1b production, and that
transfer of MDSCs protects against
invasive Candida infection.
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Despite continuous contact with fungi, immuno-
competent individuals rarely develop pro-inflamma-
tory antifungal immune responses. The underlying
tolerogenic mechanisms are incompletely under-
stood. Using both mouse models and human
patients, we show that infection with the human
pathogenic fungi Aspergillus fumigatus and Candida
albicans induces a distinct subset of neutrophilic
myeloid-derived suppressor cells (MDSCs), which
functionally suppress T and NK cell responses.
Mechanistically, pathogenic fungi induce neutro-
philic MDSCs through the pattern recognition
receptor Dectin-1 and its downstream adaptor
protein CARD9. Fungal MDSC induction is further
dependent on pathways downstream of Dectin-1
signaling, notably reactive oxygen species (ROS)
generation as well as caspase-8 activity and
interleukin-1 (IL-1) production. Additionally, exoge-
nous IL-1b induces MDSCs to comparable levels
observed during C. albicans infection. Adoptive
transfer and survival experiments show that MDSCs
are protective during invasive C. albicans infection,
but not A. fumigatus infection. These studies define
an innate immune mechanism by which pathogenic
fungi regulate host defense.CellINTRODUCTION
At mucosal sites, the human immune system is faced continu-
ously with microbes, rendering fine-tuned immune responses
essential to protect against pathogenic, while maintaining
tolerance against harmless, species. This immune balance is
of particular relevance for fungi, inhaled daily as spores or pre-
sent in the gut microflora as commensal yeasts (Romani, 2011).
While immunocompetent individuals do not develop invasive
fungal infections, infections are a major problem in patients
undergoing immunosuppression, for instance, at solid organ
or hematopoietic stem cell transplantation (Garcia-Vidal et al.,
2013).
Fungi are recognized through pattern recognition receptors,
mainly C-type lectin receptors (with Dectin-1 as the prototypic
one) (Steele et al., 2005), toll-like receptors (TLRs), and pen-
traxin 3 (PTX3) (Garlanda et al., 2002; Werner et al., 2009). A
certain level of inflammation is essential to control fungal infec-
tions (Brown, 2010), but hyperinflammatory responses seem to
cause more harm than good to the host. Particularly, Th17-
driven hyperinflammatory responses have been shown to
promote fungal growth (Zelante et al., 2012), to impair fungal
clearance, and to drive tissue damage (Romani et al., 2008;
Zelante et al., 2007). Generation of reactive oxygen species
(ROS), indoleamine 2,3-dioxygenase (IDO) activity, and activa-
tion of the TIR domain-containing adaptor-inducing interferon-b
(TRIF) pathway were found to limit hyperinflammatory re-
sponses toward Aspergillus fumigatus (Romani, 2011; Romani
et al., 2009). Yet, the cellular mechanisms by which fungiHost & Microbe 17, 507–514, April 8, 2015 ª2015 The Authors 507
control T cell activation and maintain tolerogenic host-path-
ogen bistability remain incompletely understood.
Myeloid-derived suppressor cells (MDSCs) are innate immune
cells characterized by their capacity to suppress T cell re-
sponses (Gabrilovich and Nagaraj, 2009). MDSCs comprise a
neutrophilic and amonocytic subset. While the functional impact
of MDSCs in cancer is established, their role in host-pathogen
interactions is poorly defined. We hypothesized that fungal
infections induce MDSCs that modulate disease outcome.
RESULTS
We analyzed the effect of the human-pathogenic fungi
A. fumigatus andC. albicans on human immune cells and noticed
the appearance of a cell population that was different from
monocytes (CD14), and expressed the myeloid markers
CD33+, CD11b+, CD16+, and CXCR4 (Figures 1A and S1A).
Fungi-induced myeloid cells strongly suppressed both CD4+
and CD8+ T cell proliferation in a dose-dependent manner
(Figure 1B), which defines MDSCs. Fungi-induced MDSCs also
suppressed innate natural killer (NK) cell responses, without
affecting cell survival (Figure S2). In contrast to growth factor-
induced MDSCs, fungi-induced MDSCs dampened Th2
responses, which play essential roles in fungal asthma (Kreindler
et al., 2010) (Figure S1B). We quantified MDSCs in patients
with invasive fungal infections and challenged mice with
A. fumigatus or C. albicans. MDSCs accumulated in both
A. fumigatus- and C. albicans-infected patients compared to
healthy and disease control patients without fungal infections
(Figure 1C). Murine studies further showed that systemic or pul-
monary fungal challenge with C. albicans (invasive disseminated
candidiasis) or A. fumigatus (pulmonary aspergillosis), as the
clinically relevant routes of infection, dose-dependently trig-
gered the recruitment of MDSCs in both immunocompetent
and immunosuppressed conditions, with a stronger MDSC
induction seen in immunocompetent animals (Figures 1D and
S1C). MDSCs expressed neutrophilic markers in both man and
mice, resembling the neutrophilic subtype of MDSCs (Rieber
et al., 2013), while monocytic MDSC subsets were not induced
(Figure S1D). Fungi-induced MDSCs functionally suppressed
T cell proliferation (Figure 1C), while autologous conventional
neutrophils failed to do (Figure S1E).
We adoptively transferred T cell-suppressive neutrophilic
MDSCs and monitored their impact on survival in fungal infec-
tion. While a single dose of adoptively transferred MDSCs was
protective in systemic C. albicans infection, MDSCs had no
impact on A. fumigatus infection (Figure 1E). Septic shock deter-
mines mortality in candidiasis (Spellberg et al., 2005), and the
interplay of fungal growth and renal immunopathology was
shown to correlate with host survival (Lionakis et al., 2011,
2013; Lionakis and Netea, 2013; Spellberg et al., 2003). Adop-
tively transferred MDSCs dampened renal T and NK cell activa-
tion and systemic Th17 and TNF-a cytokine responses (Figures
S1F and S1G). Conversely, supplementing IL-17A dampened
the MDSC-mediated protective effect (Figure 2A). Besides these
immunomodulatory effects, MDSCs might also act directly anti-
fungal, as our in vitro studies showed that they can phagocytose
and kill fungi (Figure 2B). However, direct antifungal effects could
hardly explain the beneficial effect of MDSCs in candidiasis: (i)508 Cell Host & Microbe 17, 507–514, April 8, 2015 ª2015 The Authoadoptively transferred MDSCs had no effect on fungal burden
in vivo (Figure 2A), (ii) inhibition of phagocytosis only partially
diminished the protection conferred by MDSCs (Figure 2A),
and (iii) MDSCs were exclusively protective in immunocompe-
tent mice (C. albicans infection model), with no effect in immuno-
suppressed (neutropenic) mice (A. fumigatus infection model).
The potency of A. fumigatus to induce MDSCs was most
pronounced for germ tubes and hyphae, morphotypes charac-
teristic for invasive fungal infections (Figure 1A) (Aimanianda
et al., 2009; Hohl et al., 2005; Moyes et al., 2010). The MDSC-
inducing fungal factor was present in conditioned supernatants
and was heat resistant (Figure 3A), pointing to b-glucans as the
bioactive component. We therefore focused on Dectin-1 as
b-glucan receptor and key fungal sensing system in myeloid
cells. Fungi-induced MDSCs expressed Dectin-1, and blocking
Dectin-1 prior to fungal exposure diminished the MDSC-
inducing effect, while blocking of TLR 4 had no effect (Figures
3B and S3). Furthermore, Dectin-1 receptor activation mimicked
the generation of neutrophilic MDSCs phenotypically and func-
tionally (Figures 3C and 3D). Dectin-1 receptor signaling was
confirmed by blocking of the spleen tyrosine kinase Syk, which
acts downstream of Dectin-1 (Figure 3B). We further used cells
from human genetic Dectin-1 deficiency and used Dectin-1
knockout mice for fungal infection models. The potential of fungi
or fungal patterns to induce neutrophilic MDSCs was diminished
in human and, albeit to a lesser extent, murine Dectin-1 defi-
ciency (Figures 3E and S1D). We analyzed the role of caspase
recruitment domain 9 (CARD9), a downstream adaptor protein
and key transducer of Dectin-1 signaling, in fungi-mediated
MDSC generation in patients with genetic CARD9 deficiency
and Card9 knockout mice. These approaches demonstrated
that CARD9 signaling was involved in fungal MDSC induction
in the human and the murine system (Figures 3E and 3F).
C. albicans induces interleukin-1 beta (IL-1b) in vitro (van de
Veerdonk et al., 2009) and in vivo (Hise et al., 2009), which is crit-
ical for antifungal immunity (Vonk et al., 2006). Recent studies
further provided evidence that IL-1b is involved inMDSC homeo-
stasis (Bruchard et al., 2013). We observed an accumulation of
intracellular IL-1b protein in CD33+ myeloid cells followed by
IL-1b release upon Dectin-1 ligand- and fungal-driven MDSC
induction (Figure 4A). IL-1b protein, in turn, was sufficient to drive
MDSC generation to a comparable extent asC. albicans did (Fig-
ure 4B). Studies in Il1r/ mice, characterized by an increased
susceptibility toC. albicans infection, demonstrated that abroga-
tion of IL-1R signaling decreased MDSC accumulation in vivo
(Figures 4B and S4A), and IL-1R antagonism in patients with
autoinflammatory diseases decreased MDSCs (Figure S4B). As
the inflammasome is the major mechanism driving IL-1b gener-
ation in myeloid cells through caspase activities, we blocked
caspases chemically. We observed that pan-caspase inhibition
largely abolished fungi-induced MDSC generation, which was
not recapitulated by caspase-1 inhibition (Figure 4C). We there-
fore focused on caspase-8, since Dectin-1 activation was shown
to trigger IL-1b processing by a caspase-8-dependent mecha-
nism (Ganesan et al., 2014; Gringhuis et al., 2012). Indeed, fungal
MDSC induction was paralleled by a substantial increase of
caspase-8 activity, and caspase-8 inhibition diminished fungal-
induced IL-1b production (Figure 4C) and the potential of
fungi to induce MDSCs (Figure 4C). Conversely, supplementingrs
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Figure 1. Fungi Induce Functional MDSCs In Vitro and In Vivo
(A) Fungal morphotypes differentially induce MDSCs.
Left panel: MDSCs were generated by incubating PBMCs (5 3 105/ml) from healthy donors with medium only (negative control), or different morphotypes of
A. fumigatus (conidia, 5 3 105/ml; germ tubes, 1 3 105/ml; hyphae, 1 3 105/ml) or C. albicans (yeasts, 1 3 105/ml; hyphae, 1 3 105/ml). The x-fold induction of
MDSCs compared to control conditions is depicted. *p < 0.05.
Right panel: representative histograms of fungi-induced MDSCs (CD11b+CD33+CD14CD16+CXCR4+).
(B) Fungi-induced MDSCs suppress T cells. The suppressive effects of CD33+-MACS-isolated MDSCs were analyzed on CD4+ and CD8+ T cell proliferation.
MDSCs were generated by incubating PBMCs (53 105/ml) from healthy donors with A. fumigatus germ tubes (13 105/ml) or C. albicans yeasts (13 105/ml) for
6 days. Different MDSC-to-T cell ratios were assessed (1:2, 1:4, 1:6, 1:8, and 1:16). The lower bar graphs represent the proliferation index compared to control
conditions as means ± SEM.
(C) MDSCs in patients with fungal infections.
Left panel: MDSCswere characterized as CD14 cells expressing CD33, CD66b, CD16, CD11b, and CXCR4 in the PBMC fraction. The gray line shows unstained
controls. MDSCs were quantified in peripheral blood from healthy controls, immunosuppressed patients without fungal infections (disease controls, n = 5), or
immunosuppressed patients with invasive fungal infections (invasive A. fumigatus infections, n = 9, and invasive C. albicans infections, n = 6). *p < 0.05.
Right panel: representative CFSE stainings, showing the effect of MDSCs isolated (MACS) from patients with invasive A. fumigatus infections (left) or invasive
C. albicans infections (right) on CD4+ and CD8+ T cell proliferation.
(D) Fungi induce MDSCs in mice in vivo.
Upper left panel: C57/BL6 (n = 3mice per treatment group) or BALB/c (n = 4mice per treatment group) wild-typemice were not infected (white bars) or challenged
intranasally with 1 3 104 (light gray bar) or 1 3 106 (dark gray bar) A. fumigatus conidia for 3 days. On the fourth day, a bronchoalveolar lavage (BAL) was
performed, and CD11b+Ly6G+ MDSCs were quantified by FACS. The x-fold induction of CD11b+Ly6G+ MDSCs in the BAL compared to control non-infected
conditions is depicted. *p < 0.05.
Upper right panel: C57BL/6 mice were not infected (white bars) or injected via the lateral tail vein with 2.5 3 105 (light gray bar) or 5 3 105 (dark gray bar)
blastospores of C. albicans. On the fifth day, mice were sacrificed, and CD11b+Ly6G+ MDSCs in the spleen were quantified by FACS. The x-fold induction of
CD11b+Ly6G+ MDSCs in the spleen compared to control non-infected conditions is depicted. n = 5 mice per treatment group. *p < 0.05.
Lower panel: bonemarrow-isolated murine CD11b+Ly6G+MDSCs were co-cultured for 3 days with T cells (CD4+ splenocytes) at a 1:2 (MDSCs:T cell) ratio. T cell
proliferation was analyzed using the CFSE assay with and without MDSCs.
(E) Adoptive transfer of MDSCs modulates survival in fungal infection. For adoptive transfer experiments, CD11b+Ly6G+ MDSCs were isolated from the bone
marrow of BALB/c mice by MACS and checked for T cell suppression. In (A)–(D) bars represent means ± SEM.
Upper panel: adoptive MDSC transfer was performed by intravenous (i.v.) injection of 53 106MDSCs per animal. Sevenmice receivedMDSCs, while sevenmice
served as non-MDSC control animals. A total of 2 hr after the MDSC transfer, mice were i.v. injected with 13 105 blastospores ofC. albicans. Mice were weighed
daily and monitored for survival and signs of morbidity.
Lower panel: for invasive pulmonary A. fumigatus infection survival studies, mice were immunosuppressed by treatment with cyclophosphamide, and MDSC
transfer was performed by i.v. injection of 43 106 MDSCs per animal. Five mice received MDSCs, while five mice served as non-MDSC control animals. After the
MDSC transfer, mice were challenged intranasally with 2 3 105 A. fumigatus conidia and were monitored for survival.
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Figure 2. Antifungal Functions
(A) In vivo.
Left panel: survival in the invasive C. albicans
infection model after adoptive MDSC transfer.
Before adoptive transfer, isolated MDSCs were
pretreated with cytochalasin D (CytD, 1 mg/ml,
green line) or with recombinant mouse IL-17A
protein (5 mg/mouse, red line).
Right panel:C. albicansCFUs in kidneys of BALB/c
mice 5 days after adoptive transfer of MDSCs.
Bars represent means ± SD.
(B) In vitro.
Left panel: 1 3 106 human MDSCs were co-
cultured with 13 105 serum opsonized C. albicans
(10:1 ratio) for 3 hr at 37C in RPMI. Serial dilutions
were performed of the cell suspension, and 100 ml
was plated onto YPD agar plates containing peni-
cillin and streptomycin. Plates were incubated for
24–48 hr at 37C, and CFU were enumerated.
Middle and right panels: phagocytic capacity of
human and murine MDSCs. Middle panel; upper
(purple) FACS plots, isolated human granulocytic
MDSCs (low-density CD66b+CD33+ cells) were co-
cultured with or without GFP-labeled C. albicans
(CA) spores (MOI = 1) in RPMI medium at 37C for
90 min. Lower (red) FACS plots, isolated mouse granulocytic CD11b+Ly6G+ MDSCs were co-cultured with or without GFP-labeled C. albicans spores (MOI = 4)
in RPMI medium at 37C for 90 min. Representative dot blots are shown.
Right panel: GFP expression/fluorescence of MDSCs was analyzed by FACS and is given in the right panel as percentage of GFP+ MDSCs.IL-1b partially restored the abrogated MDSC generation upon
caspase-8 inhibition (Figure S4C).
ROS are key factors in MDSC homeostasis (Gabrilovich and
Nagaraj, 2009) and act downstream of Dectin-1 (Gross et al.,
2009; Underhill et al., 2005). Therefore, we tested the involve-
ment of ROS for fungal Dectin-1 ligand-induced MDSC genera-
tion using chemical inhibitors and cells from human CGD
patients with ROS deficiency. These studies demonstrated that
ROS contributed substantially to fungal MDSC induction (Fig-
ure 4D). Next, we investigated the interaction between ROS,
caspase-8, and IL-1b and found that ROS inhibition dampened
caspase-8 activity in response to fungi (Figure S4D). IL-1b, in
turn, induced ROS production during MDSC culture, suggesting
a positive feedback loop between caspase-8, IL-1b, and ROS in
MDSC generation (Figures S4E and S4F).
DISCUSSION
While the complete genetic deletion of pro-inflammatory cyto-
kines, particularly TNF-a, IL-1a/b, or IFN-g, increases disease
susceptibility in invasive fungal infections (Lionakis and Netea,
2013; Cheng et al., 2012; Gow et al., 2012; Netea et al., 2008,
2010), excessive inflammation causes collateral damage to the
host (Carvalho et al., 2012; Romani et al., 2008), indicating that
efficient protection against fungi requires a fine-tuned balance
between pro-inflammatory effector and counter-regulatory im-
mune mechanisms. Fungal infection induces an immunosup-
pressive state, and in murine models CD80+ neutrophilic cells
have been shown to be importantly involved in this process
(Mencacci et al., 2002; Romani, 2011; Romani et al., 1997). By
combining human and murine experimental systems, we extend
this concept by providing evidence for an MDSC-mediated
mechanism by which fungi modulate host defense, orchestrated510 Cell Host & Microbe 17, 507–514, April 8, 2015 ª2015 The Authoby Dectin-1/CARD9, ROS, caspase-8, and IL-1b. This effect
seems to be specific for neutrophilic MDSCs, since monocytic
MDSCs were unchanged under our experimental conditions
and were previously found to be downregulated by b-glucans
in tumor-bearing mice (Tian et al., 2013).
C. albicans and A. fumigatus infections differ substantially with
respect to T cell dependency and organ manifestation (Garcia-
Vidal et al., 2013). Our finding that neutrophilic MDSCswere pro-
tective in a murine model of systemic C. albicans infection, but
had no effect on pulmonary A. fumigatus infection, underlines
this disparity and suggests MDSCs as a potential therapeutic
approach in invasive C. albicans, rather than A. fumigatus infec-
tions. The MDSC-mediated effect was associated with down-
regulated NK and T cell activation, and Th17 responses and
supplementing IL-17A in vivo could, at least partially, dampen
the protective effect of MDSCs. Based on previous studies
showing that NK cells drive hyperinflammation in candidiasis in
immunocompetent mice (Quintin et al., 2014) and that IL-17 pro-
motes fungal survival (Zelante et al., 2012), we speculate that
MDSCs in fungal infections could act beneficial for the host
by dampening pathogenic hyperinflammatory NK and Th17 re-
sponses (Romani et al., 2008; Zelante et al., 2007). Accordingly,
enhancing neutrophilic MDSCsmay represent an anti-inflamma-
tory treatment strategy for fungal infections, particularly with
C. albicans.
Recent studies put the gut in the center of immunotolerance.
Dectin-1 was found to control colitis and intestinal Th17 re-
sponses through sensing of the fungal mycobiome (Iliev et al.,
2012). The immunological events downstream of Dectin-1 and
their functional impact on Th17 cells remained elusive. Our re-
sults demonstrate that fungal Dectin-1/CARD9 signaling induces
MDSCs todampenTcell responses andsuggest that the immune
homeostasis in the gut could be modulated by fungal-inducedrs
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Figure 3. Fungi Induce MDSCs through a Dectin-1-, Syk-, and CARD9-Mediated Mechanism
(A) Fungal factors mediating MDSC induction are heat resistant. MDSCs were generated by incubating PBMCs (5 3 105/ml) from healthy donors with medium
only (negative control), untreated, or heat-denatured (95C, 30min) supernatants (SNT) ofA. fumigatus germ tubes (4%) for 6 days. The x-fold induction ofMDSCs
compared to control conditions is depicted. *p < 0.05 versus control conditions.
(B) Dectin-1 and Syk are involved in fungal MDSC induction. MDSCs were generated in vitro by incubating isolated PBMCs (5 3 105 cells/ml) with A. fumigatus
germ tubes (1 3 105/ml), hyphae (1 3 105/ml), and C. albicans yeasts (1 3 105/ml) for 6 days. Where indicated, PBMCs were pretreated for 60 min with anti-
Dectin-1 blocking antibody (15 mg/ml), soluble WGP (1 mg/ml), and a Syk inhibitor (100 nM). *p < 0.05 blocking versus unblocked conditions.
(C) Dectin-1/CARD9 ligands mimic fungal MDSC induction. MDSCs were generated in vitro by incubating isolated PBMCs with the Dectin-1/CARD9 ligands
zymosan depleted (10 mg/ml), dispersible WGP (20 mg/ml), or curdlan (10 mg/ml). p < 0.05 versus control conditions.
(D) Dectin-1/CARD9 ligands induce functional MDSCs. The suppressive effects of CD33+-MACS-isolated MDSCs were analyzed on CD4+ and CD8+ T cell
proliferation (CFSE polyclonal proliferation assay). MDSCs were generated by incubating PBMCs (5 3 105/ml) from healthy donors with zymosan depleted
(10 mg/ml) or dispersible WGP (20 mg/ml). MDSC, T cell ratio was 1:6.
(E) Fungal MDSC induction in patients with genetic Dectin-1 or CARD9 deficiency.
Left panel: MDSCswere generated in vitro by incubating isolated PBMCs (53 105 cells/ml) from healthy controls (n = 12), an individual with Dectin-1 deficiency, or
patients with CARD9 deficiency (n = 2) with the Dectin-1/CARD9 ligands zymosan depleted (10 mg/ml) or dispersible WGP (20 mg/ml).
Right panel: MDSCs were generated in vitro by incubating isolated PBMCs (53 105 cells/ml) from healthy controls (n = 12), an individual with genetically proven
Dectin-1 deficiency, or patients with CARD9 deficiency (n = 2) with different fungal morphotypes (1 3 105 cells/ml) for 6 days.
(F) CARD9 is involved in fungi-induced MDSC recruitment in vivo. Card9/ mice and age-matched wild-type mice were challenged intranasally with 1 3 106
A. fumigatus conidia for 3 days. On the fourth day, a BAL was performed, and CD11b+Ly6G+ MDSCs were quantified by flow cytometry. In (B), (C), and (E) bars
represent means ± SEM.MDSCs. Beyond fungi, the Dectin-1/CARD9 pathway has been
involved in bacterial and viral infections (Hsu et al., 2007),
suggesting that this mechanism could play a broader role in
balancing inflammation at host-pathogen interfaces.
EXPERIMENTAL PROCEDURES
Fungal Strains and Culture Conditions
A. fumigatus ATCC46645 conidia were incubated in RPMI at RT for 3 hr at
150 rpm to become swollen. Alternatively, conidia were cultured in RPMI over-
night at RT, followed by germination in RPMI either at 37C for 3 hr at 150 rpm
to become germ tubes or at 37C for 17 hr at 150 rpm to become hyphae.
C. albicans SC5314 was grown on SAB agar plates at 25C. One colony
was inoculated and shaken at 200 rpm at 30C in SAB broth overnight. To
generate hyphae, live yeast forms of C. albicans were grown for 6 hr at 37C
in RPMI 1640. Killed yeasts and hyphae were prepared by heat treatment of
the cell suspension at 95C for 45 min or by fixing the cells for 1 hr with 4%
paraformaldehyde followed by extensive washing with PBS to completely
remove the fixing agent. The C. albicans-GFP strain TG6 was pre-cultured at
30C, 200 rpm overnight in YPD medium.CellGeneration, Isolation, and Characterization of MDSCs
Neutrophilic MDSCs in peripheral blood were quantified based on their lower
density and surface marker profiles as published previously (Rieber et al.,
2013). Human MDSCs were generated in vitro according to a published
protocol (Lechner et al., 2010). Murine MDSCs were characterized by
CD11b, Ly6G, and Ly6C. Flow cytometry was performed on a FACS Calibur
(BD Biosciences). Human and murine MDSCs were isolated using MACS
(MDSC Isolation Kit; Miltenyi Biotec).
T Cell Suppression Assays
T cell suppression assays were performed as described previously (Rieber
et al., 2013) using the CFSE method according to the manufacturer’s protocol
(Invitrogen).
Mouse Infection with A. fumigatus and C. albicans
Invasive C. albicans infection was established by IV injection in immunocom-
petent mice, whereas A. fumigatus infection was established by intranasal
challenge in immunosuppressed mice. CD11b+Ly6G+ and CD11b+Ly6C+
cells in the spleens, BAL, and kidneys were quantified by FACS. For adoptive
transfer experiments, CD11b+Ly6G+ MDSCs were isolated by MACS and
transferred by IV injection of 4 or 5 3 106 MDSCs per animal.Host & Microbe 17, 507–514, April 8, 2015 ª2015 The Authors 511
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Figure 4. Fungal MDSC Induction Involves IL-1b, Caspase-8, and ROS
(A) Intracellular accumulation and release of IL-1b.
Left panel: gating strategy for intracellular cytokine staining. IL-1b was analyzed in CD33+ myeloid cells using intracellular cytokine staining and flow cytometry.
Zymosan depleted (20, 100, and 500 mg/ml) and WGP dispersible (20, 100, and 500 mg/ml) were used for 1 hr to stimulate cytokine production.
Middle panel: leukocytes isolated from healthy donors (n = 4) were left untreated (empty circles) or were treated for 1 hr with increasing concentrations of
zymosan, WGP, A. fumigatus germ tubes, or C. albicans yeasts (each at 23 105/ml and 13 106/ml). IL-1b synthesis in CD33+ cells was analyzed by intracellular
cytokine stainings by flow cytometry. *p < 0.05 versus control/untreated conditions.
Right panel: co-culture supernatants were collected after incubating isolated PBMCs (5 3 105 cells/ml) with medium only (white bar), A. fumigatus germ tubes
(1 3 105 cells/ml), or C. albicans yeasts (1 3 105/ml) for 3 days. IL-1b was quantified by ELISA. *p < 0.05 versus medium control conditions.
(B) IL-1b signaling is involved in fungal-induced MDSC generation.
Left panel: MDSCs were generated in vitro by incubating isolated PBMCs (5 3 105 cells/ml) with C. albicans yeasts (1 3 105/ml) or recombinant human IL-1b
protein (0.01 mg/ml) for 6 days. *p < 0.05.
Right panel: MDSCs (CD11b+Ly6G+) were quantified in spleens from Il1r/ and age-matched WT mice 2 days after i.v. infection with 1 3 105 blastospores of
C. albicans. *p < 0.05.
(C) Fungal MDSC generation involves caspase-8. MDSCs were generated in vitro by incubating isolated PBMCs (5 3 105 cells/ml) with C. albicans yeasts
(13 105/ml) for 6 days with or without pretreatment (where indicated) with the pan-caspase inhibitor Z-VAD-FMK (10 mM), the caspase-1 inhibitor Z-WEHD-FMK
(50 mM), or the caspase-8 inhibitor Z-IETD-FMK (50 mM). IL-1b protein levels were quantified in cell culture supernatants by ELISA (note: two values were below
detection limit). Caspase-8 activity was quantified in cell lysates using a luminescent assay. *p < 0.05.
(legend continued on next page)
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